Compare PCYO & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCYO | RPID |
|---|---|---|
| Founded | 1976 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 242.8M | 204.3M |
| IPO Year | 1995 | 2021 |
| Metric | PCYO | RPID |
|---|---|---|
| Price | $9.83 | $2.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 43.8K | ★ 230.2K |
| Earning Date | 04-08-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.50 | 2.78 |
| EPS | ★ 0.19 | N/A |
| Revenue | $1,227,787.00 | ★ $33,587,000.00 |
| Revenue This Year | N/A | $19.12 |
| Revenue Next Year | N/A | $18.42 |
| P/E Ratio | $52.00 | ★ N/A |
| Revenue Growth | ★ 171.54 | 19.74 |
| 52 Week Low | $9.65 | $1.86 |
| 52 Week High | $12.16 | $4.94 |
| Indicator | PCYO | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 36.57 | 29.50 |
| Support Level | N/A | N/A |
| Resistance Level | $10.66 | $3.74 |
| Average True Range (ATR) | 0.32 | 0.29 |
| MACD | -0.01 | -0.13 |
| Stochastic Oscillator | 5.41 | 1.79 |
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.